Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $120

Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $120

Piper Sandler analyst Matt O'Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $110 to $120.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Piper Sandler analyst Matt O’Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $110 to $120.

Porsche IPO Commands Valuation Of Up To $85B Amid Global Headwinds: Report

By Anusuya Lahiri

August 29, 8:29 AM

Porsche drew investor interest for its initial public offering at a valuation of up to $85 billion, despite…

LVMUY

UBS Maintains Buy on AT&T, Lowers Price Target to $24

By Benzinga Newsdesk

July 22, 9:56 AM

UBS analyst John Hodulik maintains AT&T (NYSE:T) with a Buy and lowers the price target from $25 to $24.

Binance CEO Changpeng Zhao Predicts Massive Trading Surge On The Horizon

By Murtuza Merchant

July 5, 6:54 PM

Binance (CRYPTO: BNB) CEO Changpeng "CZ" Zhao stated on Tuesday that the company is preparing for an anticipated surge in trading volume over the next six to 18 months.

$BNB

Truist Securities Maintains Buy on APA, Lowers Price Target to $63

By Benzinga Newsdesk

January 19, 8:45 AM

Truist Securities analyst Neal Dingmann maintains APA (NASDAQ:APA) with a Buy and lowers the price target from $69 to $63.

APA

Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $120

Related Posts

Porsche IPO Commands Valuation Of Up To $85B Amid Global Headwinds: Report

UBS Maintains Buy on AT&T, Lowers Price Target to $24

Binance CEO Changpeng Zhao Predicts Massive Trading Surge On The Horizon

Truist Securities Maintains Buy on APA, Lowers Price Target to $63